Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB capsules: a post-hoc analysis of a randomized controlled trial.
Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB supplement capsule: A randomized control trial.
8052 using different concentrations of cassava starch.
Listonella) anguillarum NCIMB
571) and phenon 6 (17 isolates and the reference strain of V.
reuteri NCIMB 30242, which supports normal cholesterol levels and inflammatory response.
reuteri NCIMB 30242 which work together to maintain the balance of healthy bacteria in your gut and support normal digestive function.
reuteri NCIMB 30242 twice a day, while the rest were given placebo capsules.
reuteri NCIMB 30242 was fermented and formulated to optimize its effect on cholesterol and bile salts.
10] used direct screening of unsequenced bacterial genome library for characterization of a putrescine oxidase from Rhodococcus erythropolis NCIMB
Experts from NCIMB
Ltd, a spin-off firm from Aberdeen University, aim to perfect a test kit which will detect bacteria during quality control checks.
27, 2013 /PRNewswire/ -- Micropharma Limited, a pioneer in the development of innovative and effective probiotics, today announced that their heart health probiotic, Cardioviva (TM)(Lactobacillus reuteri NCIMB
30242), has obtained "Generally Recognized as Safe" (GRAS) status.
Mitchell Jones, Micropharma chief scientific officer and co-founder, will present new clinical results about Cardioviva (TM)(Lactobacillus reuteri NCIMB
30242) at an oral presentation entitled "Probiotics for Heart Health: Next Generation of Adjunct Therapies for Lipid Management," at the American Heart Association (AHA) Scientific Sessions on Nov.